Ariane Tabatabai

Georgetown University / Bulletin of the Atomic Scientists

Guest

Ariane Tabatabai is director of curriculum in the Security Studies Program at Georgetown University and a postdoctoral fellow at the Harvard Kennedy School's Belfer Center. She is a columnist at the Bulletin of the Atomic Scientists.

Ariane Tabatabai on KCRW

In 2015, the Obama Administration struck a landmark deal with Iran and other world powers to curtail the Iranian nuclear program.

Trump Administration takes a new hard line approach to Iran

In 2015, the Obama Administration struck a landmark deal with Iran and other world powers to curtail the Iranian nuclear program.

from To the Point

More from KCRW

Special coverage of the 47th US Presidential Inauguration live in Washington D.C. from NPR.

from News Special Programming

The arrest of a student protester raises questions on free speech. Is the White House picking which speech is illegal, or are they enforcing anti-discrimination laws?

from Left, Right & Center

The American saber-rattling against China has been increasing almost as fast as China’s own development in the past few years.

from Scheer Intelligence

The assassination of Brian Thompson, the former CEO of UnitedHealthcare insurance company, has prompted a national reckoning of how corporate entities commit crimes on a daily basis…

from Scheer Intelligence

The right says it’s pushing back on cancel culture. Are they just redefining it? Plus, the president banishes pennies and paper straws.

from Left, Right & Center

Should the U.S. worry about post-Assad Syria? What’s behind the support for the man who fatally shot UHC’s CEO? Plus, KCRW discusses how sports fandom crossed into politics.

from Left, Right & Center

NPR's Live Special Coverage of Trump’s address will begin at 6 PM PT.

from News Special Programming

What can we expect from President-elect Trump’s inauguration? Will he squander the goodwill of the moment? Plus, KCRW takes pre-inauguration audience questions.

from Left, Right & Center

Five years after the pandemic started, 2 million people still need treatment for long COVID. Doctors say there’s much yet to learn about the condition.

from KCRW Features